NEWS
Our Latest News
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
Private equity healthcare specialist ARCHIMED announces the sale of DIESSE to private equity firm Fremman Capital. The transaction caps a five-year partnership with DIESSE and marks the latter’s transformation into a leading clinical diagnostics innovator. The deal returns 4.6 times invested capital to shareholders.
ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge
December
12,
2019
ARCHIMED appoints three new operating and strategic partners
November
19,
2019
Flash News – Bomi Group launches its 2019-2020 Welfare Plan
November
19,
2019
Provepharm Life Solutions lauréate du prix Galien MedStartUp 2018
November
19,
2019
368